811 related articles for article (PubMed ID: 34506130)
1. Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode.
Lockbaum GJ; Henes M; Lee JM; Timm J; Nalivaika EA; Thompson PR; Kurt Yilmaz N; Schiffer CA
Biochemistry; 2021 Oct; 60(39):2925-2931. PubMed ID: 34506130
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for antiviral inhibition of the main protease, 3C, from human enterovirus 93.
Costenaro L; Kaczmarska Z; Arnan C; Janowski R; Coutard B; Solà M; Gorbalenya AE; Norder H; Canard B; Coll M
J Virol; 2011 Oct; 85(20):10764-73. PubMed ID: 21835784
[TBL] [Abstract][Full Text] [Related]
3. Structure of the HRV-C 3C-Rupintrivir Complex Provides New Insights for Inhibitor Design.
Yuan S; Fan K; Chen Z; Sun Y; Hou H; Zhu L
Virol Sin; 2020 Aug; 35(4):445-454. PubMed ID: 32103448
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues.
Wang J; Fan T; Yao X; Wu Z; Guo L; Lei X; Wang J; Wang M; Jin Q; Cui S
J Virol; 2011 Oct; 85(19):10021-30. PubMed ID: 21813612
[TBL] [Abstract][Full Text] [Related]
5. Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design.
Lu G; Qi J; Chen Z; Xu X; Gao F; Lin D; Qian W; Liu H; Jiang H; Yan J; Gao GF
J Virol; 2011 Oct; 85(19):10319-31. PubMed ID: 21795339
[TBL] [Abstract][Full Text] [Related]
6. Structures of Enterovirus 71 3C proteinase (strain E2004104-TW-CDC) and its complex with rupintrivir.
Wu C; Cai Q; Chen C; Li N; Peng X; Cai Y; Yin K; Chen X; Wang X; Zhang R; Liu L; Chen S; Li J; Lin T
Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):866-71. PubMed ID: 23633597
[TBL] [Abstract][Full Text] [Related]
7. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.
Forrestall KL; Burley DE; Cash MK; Pottie IR; Darvesh S
Chem Biol Interact; 2021 Feb; 335():109348. PubMed ID: 33278462
[TBL] [Abstract][Full Text] [Related]
8. A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors*.
Yang KS; Ma XR; Ma Y; Alugubelli YR; Scott DA; Vatansever EC; Drelich AK; Sankaran B; Geng ZZ; Blankenship LR; Ward HE; Sheng YJ; Hsu JC; Kratch KC; Zhao B; Hayatshahi HS; Liu J; Li P; Fierke CA; Tseng CK; Xu S; Liu WR
ChemMedChem; 2021 Mar; 16(6):942-948. PubMed ID: 33283984
[TBL] [Abstract][Full Text] [Related]
9. Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188.
Lockbaum GJ; Reyes AC; Lee JM; Tilvawala R; Nalivaika EA; Ali A; Kurt Yilmaz N; Thompson PR; Schiffer CA
Viruses; 2021 Jan; 13(2):. PubMed ID: 33503819
[TBL] [Abstract][Full Text] [Related]
10. In Silico Characterization of Masitinib Interaction with SARS-CoV-2 Main Protease.
Martínez-Ortega U; Figueroa-Figueroa DI; Hernández-Luis F; Aguayo-Ortiz R
ChemMedChem; 2021 Aug; 16(15):2339-2344. PubMed ID: 34142459
[TBL] [Abstract][Full Text] [Related]
11. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.
Anand K; Ziebuhr J; Wadhwani P; Mesters JR; Hilgenfeld R
Science; 2003 Jun; 300(5626):1763-7. PubMed ID: 12746549
[TBL] [Abstract][Full Text] [Related]
12. In silico Study to Evaluate the Antiviral Activity of Novel Structures against 3C-like Protease of Novel Coronavirus (COVID-19) and SARS-CoV.
Chunduru K; Sankhe R; Begum F; Sodum N; Kumar N; Kishore A; Shenoy RR; Rao CM; Saravu K
Med Chem; 2021; 17(4):380-395. PubMed ID: 32720605
[TBL] [Abstract][Full Text] [Related]
13. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.
Binford SL; Maldonado F; Brothers MA; Weady PT; Zalman LS; Meador JW; Matthews DA; Patick AK
Antimicrob Agents Chemother; 2005 Feb; 49(2):619-26. PubMed ID: 15673742
[TBL] [Abstract][Full Text] [Related]
14. Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors.
Amin SA; Banerjee S; Ghosh K; Gayen S; Jha T
Bioorg Med Chem; 2021 Jan; 29():115860. PubMed ID: 33191083
[TBL] [Abstract][Full Text] [Related]
15. Identification of non-covalent SARS-CoV-2 main protease inhibitors by a virtual screen of commercially available drug-like compounds.
Zhang L; Howland M; Hilgenfeld R; Anderson MO; Eagon S
Bioorg Med Chem Lett; 2021 Jun; 41():127990. PubMed ID: 33775840
[TBL] [Abstract][Full Text] [Related]
16. Structure and inhibition of SARS-CoV-1 and SARS-CoV-2 main proteases by oral antiviral compound AG7404.
Fàbrega-Ferrer M; Herrera-Morandé A; Muriel-Goñi S; Pérez-Saavedra J; Bueno P; Castro V; Garaigorta U; Gastaminza P; Coll M
Antiviral Res; 2022 Dec; 208():105458. PubMed ID: 36336176
[TBL] [Abstract][Full Text] [Related]
17. Structure-Based Discovery and Structural Basis of a Novel Broad-Spectrum Natural Product against the Main Protease of Coronavirus.
Zhang Y; Gao H; Hu X; Wang Q; Zhong F; Zhou X; Lin C; Yang Y; Wei J; Du W; Huang H; Zhou H; He W; Zhang H; Zhang Y; McCormick PJ; Fu J; Wang D; Fu Y; Lu X; Zhang T; Duan J; Qin B; Jiang H; Luo J; Zhang Y; Chen Q; Luo Q; Cheng L; Zhang Z; Zhang J; Li J
J Virol; 2022 Jan; 96(1):e0125321. PubMed ID: 34586857
[TBL] [Abstract][Full Text] [Related]
18. Structure-Activity Relationships of Benzamides and Isoindolines Designed as SARS-CoV Protease Inhibitors Effective against SARS-CoV-2.
Welker A; Kersten C; Müller C; Madhugiri R; Zimmer C; Müller P; Zimmermann R; Hammerschmidt S; Maus H; Ziebuhr J; Sotriffer C; Schirmeister T
ChemMedChem; 2021 Jan; 16(2):340-354. PubMed ID: 32930481
[TBL] [Abstract][Full Text] [Related]
19. The enterovirus protease inhibitor rupintrivir exerts cross-genotypic anti-norovirus activity and clears cells from the norovirus replicon.
Rocha-Pereira J; Nascimento MS; Ma Q; Hilgenfeld R; Neyts J; Jochmans D
Antimicrob Agents Chemother; 2014 Aug; 58(8):4675-81. PubMed ID: 24890597
[TBL] [Abstract][Full Text] [Related]
20. RIPK1 Is Cleaved by 3C Protease of Rhinovirus A and B Strains and Minor and Major Groups.
Croft SN; Walker EJ; Ghildyal R
Viruses; 2021 Nov; 13(12):. PubMed ID: 34960671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]